|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Pieris Pharmaceuticals (NASDAQ: PIRS) through any online brokerage.
The latest price target for Pieris Pharmaceuticals (NASDAQ: PIRS) was reported by Baird on March 13, 2020. The analyst firm set a price target for 5.00 expecting PIRS to rise to within 12 months (a possible 41.64% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Pieris Pharmaceuticals (NASDAQ: PIRS) is $3.53 last updated Fri Jun 18 2021 20:00:03 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Pieris Pharmaceuticals.
There is no upcoming split for Pieris Pharmaceuticals.
Pieris Pharmaceuticals is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.